Literature DB >> 14735402

Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.

S García-Bujalance1, G Ruiz, C Ladrón De Guevara, J M Peña, I Bates, J J Vázquez, A Gutiérrez.   

Abstract

The purpose of this study was to analyze the quantitation of the human immunodeficiency virus type 1 RNA (HIV-1 RNA) in the genital tract of HIV-1-infected pregnant women and to evaluate a possible correlation with the viral load in blood plasma (Spearman's rank correlation coefficient). A total of 38 each of cervical, vaginal, and blood samples from 38 women were obtained during the third trimester of pregnancy for quantitation of the HIV-1 RNA load. Viral loads were determined by reverse transcription-polymerase chain reaction. The HIV-1 RNA viral load was detectable in 29 of the 38 (76.3%) blood samples, in 6 of the 38 (15.7%) cervical secretion samples, and in 8 of the 38 (21%) vaginal secretion samples. Overall, the correlation between the HIV-1 RNA viral load in the blood plasma and in cervical secretion samples was 0.51 ( P<0.001). However, the correlation disappeared ( r=0.27) when three patients with high blood plasma viral loads were eliminated from the statistical study. The viral load in the vaginal secretions did not correlate with that in the blood samples ( r=0.26). There were two cases in which HIV-1 RNA was undetectable in the blood and cervix but was detectable in vaginal secretions: one woman had 220 copies/ml and the other 68 copies/ml. These results suggest that pregnant women with undetectable viral loads in blood plasma are still at risk of transmitting the virus vertically during vaginal delivery. Because of this, antiretroviral prophylaxis during vaginal delivery must be administered to HIV-1-infected women and their newborns, regardless of the mother's viral load in plasma. In conclusion, quantification of cervicovaginal levels of HIV-1 may represent a useful tool for assessing the individual risk associated with a vaginal delivery and for guiding decisions about whether a scheduled caesarean should be recommended.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735402     DOI: 10.1007/s10096-003-1058-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

Review 1.  [Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society].

Authors:  J A Iribarren; J T Ramos; L Guerra; O Coll; M I de José; P Domingo; C Fortuny; P Miralles; F Parras; J M Peña; C Rodrigo; R Vidal
Journal:  Enferm Infecc Microbiol Clin       Date:  2001 Aug-Sep       Impact factor: 1.731

2.  Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.

Authors:  S Rasheed; Z Li; D Xu; A Kovacs
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Authors:  Lynne M Mofenson
Journal:  MMWR Recomm Rep       Date:  2002-11-22

4.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

5.  Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.

Authors:  M Debiaggi; F Zara; A Spinillo; A De Santolo; R Maserati; R Bruno; P Sacchi; G Achilli; A Pistorio; E Romero; G Filice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

6.  Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).

Authors:  A Si-Mohamed; L Andreoletti; I Colombet; M P Carreno; G Lopez; G Chatelier; M D Kazatchkine; L Belec
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

8.  Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.

Authors:  F Shaheen; A V Sison; L McIntosh; M Mukhtar; R J Pomerantz
Journal:  J Hum Virol       Date:  1999 May-Jun

9.  Exposure to HIV-1 during delivery and mother-to-child transmission.

Authors:  P Gaillard; C Verhofstede; F Mwanyumba; P Claeys; V Chohan; K Mandaliya; J Bwayo; J Plum; M Temmerman
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

10.  Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  R Chuachoowong; N Shaffer; W Siriwasin; P Chaisilwattana; N L Young; P A Mock; S Chearskul; N Waranawat; T Chaowanachan; J Karon; R J Simonds; T D Mastro
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

View more
  12 in total

1.  Understanding HIV viral load: implications for counselling.

Authors:  Patrick O'Byrne; Paul A MacPherson
Journal:  Can J Public Health       Date:  2008 May-Jun

2.  Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum.

Authors:  Ahizechukwu C Eke; Nahida Chakhtoura; Angela Kashuba; Brookie M Best; Craig Sykes; Jiajia Wang; Alice M Stek; Elizabeth Smith; Samantha Calabrese; Edmund V Capparelli; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2018-07-01       Impact factor: 3.731

3.  The effects of chronic binge alcohol on the genital microenvironment of simian immunodeficiency virus-infected female rhesus macaques.

Authors:  Nisha Loganantharaj; Whitney A Nichols; Gregory J Bagby; Julia Volaufova; Jason Dufour; David H Martin; Steve Nelson; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-08       Impact factor: 2.205

4.  Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

Authors:  Michael N Neely; Lorie Benning; Jiaao Xu; Howard D Strickler; Ruth M Greenblatt; Howard Minkoff; Mary Young; James Bremer; Alexandra M Levine; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

5.  Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.

Authors:  Kerina Duri; Felicity Z Gumbo; Knut I Kristiansen; Nyaradzi E Kurewa; Munyaradzi P Mapingure; Simbarashe Rusakaniko; Mike Z Chirenje; Fredrik Muller; Babill Stray-Pedersen
Journal:  Virol J       Date:  2010-08-02       Impact factor: 4.099

6.  Novel methodology for antiretroviral quantitation in the female genital tract.

Authors:  Chantelle Bennetto-Hood; Victoria A Johnson; Jennifer R King; Craig J Hoesley; Edward P Acosta
Journal:  HIV Clin Trials       Date:  2009 May-Jun

7.  Mother-to-child transmission of human immunodeficiency virus in aten years period.

Authors:  Adriane M Delicio; Helaine Milanez; Eliana Amaral; Sirlei S Morais; Giuliane J Lajos; João Luiz C Pinto e Silva; José Guilherme Cecatti
Journal:  Reprod Health       Date:  2011-11-30       Impact factor: 3.223

8.  Global discourses and experiential speculation: Secondary and tertiary graduate Malawians dissect the HIV/AIDS epidemic.

Authors:  Tyler W Myroniuk
Journal:  J Int AIDS Soc       Date:  2011-10-04       Impact factor: 5.396

9.  Acute HIV Infection in Pregnancy: The Case for Third Trimester Rescreening.

Authors:  Jocelyn Wertz; Jason Cesario; Jennifer Sackrison; Sean Kim; Chi Dola
Journal:  Case Rep Infect Dis       Date:  2011-12-22

10.  Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis.

Authors:  Aditya S Khanna; Sarah T Roberts; Susan Cassels; Roger Ying; Grace John-Stewart; Steven M Goodreau; Jared M Baeten; Pamela M Murnane; Connie Celum; Ruanne V Barnabas
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.